

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 6.62501868 |
| 2 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.47496529 |
| 3 | ATP synthesis coupled proton transport (GO:0015986) | 6.07503712 |
| 4 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.07503712 |
| 5 | respiratory electron transport chain (GO:0022904) | 5.42340770 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 5.34756589 |
| 7 | electron transport chain (GO:0022900) | 5.27822263 |
| 8 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.04841612 |
| 9 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.66590538 |
| 10 | oxygen transport (GO:0015671) | 4.58973123 |
| 11 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48810343 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.47631298 |
| 13 | protein complex biogenesis (GO:0070271) | 4.46395335 |
| 14 | protein-cofactor linkage (GO:0018065) | 4.41599772 |
| 15 | proteasome assembly (GO:0043248) | 4.41337272 |
| 16 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.33007525 |
| 17 | negative regulation of cell killing (GO:0031342) | 4.33007525 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.30857446 |
| 19 | chaperone-mediated protein transport (GO:0072321) | 4.26037151 |
| 20 | regulation of mitochondrial translation (GO:0070129) | 4.18679340 |
| 21 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.15506623 |
| 22 | NADH dehydrogenase complex assembly (GO:0010257) | 4.15506623 |
| 23 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.15506623 |
| 24 | positive regulation of mast cell activation (GO:0033005) | 4.12051812 |
| 25 | neutrophil activation (GO:0042119) | 4.05785650 |
| 26 | gas transport (GO:0015669) | 3.86710576 |
| 27 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.85759194 |
| 28 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 3.83650060 |
| 29 | positive regulation of protein homodimerization activity (GO:0090073) | 3.77309001 |
| 30 | metallo-sulfur cluster assembly (GO:0031163) | 3.77232067 |
| 31 | iron-sulfur cluster assembly (GO:0016226) | 3.77232067 |
| 32 | granulocyte activation (GO:0036230) | 3.72542063 |
| 33 | regulation of mast cell degranulation (GO:0043304) | 3.72379173 |
| 34 | regulation of mast cell activation (GO:0033003) | 3.68150209 |
| 35 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.67633967 |
| 36 | termination of RNA polymerase III transcription (GO:0006386) | 3.67633967 |
| 37 | dopamine transport (GO:0015872) | 3.66784972 |
| 38 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.64831793 |
| 39 | protein neddylation (GO:0045116) | 3.64049019 |
| 40 | positive regulation by symbiont of host defense response (GO:0052509) | 3.60616171 |
| 41 | modulation by symbiont of host defense response (GO:0052031) | 3.60616171 |
| 42 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.60616171 |
| 43 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.60616171 |
| 44 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.60616171 |
| 45 | modulation by symbiont of host immune response (GO:0052553) | 3.60616171 |
| 46 | hydrogen ion transmembrane transport (GO:1902600) | 3.57253242 |
| 47 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.55291027 |
| 48 | microglial cell activation (GO:0001774) | 3.50801954 |
| 49 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.49498638 |
| 50 | cellular extravasation (GO:0045123) | 3.45022876 |
| 51 | ATP biosynthetic process (GO:0006754) | 3.40982252 |
| 52 | establishment of skin barrier (GO:0061436) | 3.40226648 |
| 53 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.38755593 |
| 54 | positive regulation of mast cell degranulation (GO:0043306) | 3.38755593 |
| 55 | oxidative phosphorylation (GO:0006119) | 3.37461540 |
| 56 | response to peptidoglycan (GO:0032494) | 3.34978804 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.34317986 |
| 58 | respiratory chain complex IV assembly (GO:0008535) | 3.31791239 |
| 59 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.30636587 |
| 60 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.28512885 |
| 61 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.27761017 |
| 62 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.27761017 |
| 63 | cytochrome complex assembly (GO:0017004) | 3.27565555 |
| 64 | leukocyte degranulation (GO:0043299) | 3.27533953 |
| 65 | regulation of oxidative phosphorylation (GO:0002082) | 3.27311151 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 3.26692689 |
| 67 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.26592222 |
| 68 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.25432693 |
| 69 | myeloid cell activation involved in immune response (GO:0002275) | 3.23735433 |
| 70 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.23339646 |
| 71 | transferrin transport (GO:0033572) | 3.19981879 |
| 72 | proton transport (GO:0015992) | 3.18908308 |
| 73 | regulation of cellular respiration (GO:0043457) | 3.17902708 |
| 74 | righting reflex (GO:0060013) | 3.15989692 |
| 75 | startle response (GO:0001964) | 3.15951790 |
| 76 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.15860699 |
| 77 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.15533453 |
| 78 | regulation of gamma-delta T cell activation (GO:0046643) | 3.15125083 |
| 79 | detection of other organism (GO:0098543) | 3.12345411 |
| 80 | hydrogen transport (GO:0006818) | 3.12038248 |
| 81 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.11867090 |
| 82 | DNA damage response, detection of DNA damage (GO:0042769) | 3.10901017 |
| 83 | protein targeting to mitochondrion (GO:0006626) | 3.10646340 |
| 84 | autophagic vacuole fusion (GO:0000046) | 3.08549101 |
| 85 | inner mitochondrial membrane organization (GO:0007007) | 3.08428367 |
| 86 | positive regulation of granulocyte differentiation (GO:0030854) | 3.06576468 |
| 87 | 7-methylguanosine mRNA capping (GO:0006370) | 3.05508698 |
| 88 | detection of bacterium (GO:0016045) | 3.05119633 |
| 89 | rRNA modification (GO:0000154) | 3.03913506 |
| 90 | establishment of protein localization to mitochondrion (GO:0072655) | 3.03672205 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.02549022 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 3.02418621 |
| 93 | RNA capping (GO:0036260) | 3.01113882 |
| 94 | 7-methylguanosine RNA capping (GO:0009452) | 3.01113882 |
| 95 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.00567342 |
| 96 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.00567342 |
| 97 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.99742420 |
| 98 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.96830614 |
| 99 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.95247117 |
| 100 | GTP biosynthetic process (GO:0006183) | 2.94426760 |
| 101 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.94087229 |
| 102 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.93521301 |
| 103 | regulation of platelet aggregation (GO:0090330) | 2.93034879 |
| 104 | ferric iron transport (GO:0015682) | 2.92553323 |
| 105 | trivalent inorganic cation transport (GO:0072512) | 2.92553323 |
| 106 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.92350089 |
| 107 | regulation of leukocyte degranulation (GO:0043300) | 2.91868505 |
| 108 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.91475283 |
| 109 | NADH metabolic process (GO:0006734) | 2.90111282 |
| 110 | N-acetylneuraminate metabolic process (GO:0006054) | 2.89315549 |
| 111 | negative regulation of interleukin-1 production (GO:0032692) | 2.88973429 |
| 112 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83123822 |
| 113 | aerobic respiration (GO:0009060) | 2.82086692 |
| 114 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.81804670 |
| 115 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.81589471 |
| 116 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.81349654 |
| 117 | neuron cell-cell adhesion (GO:0007158) | 2.80402460 |
| 118 | neurofilament cytoskeleton organization (GO:0060052) | 2.80374450 |
| 119 | macrophage activation (GO:0042116) | 2.78999987 |
| 120 | quinone biosynthetic process (GO:1901663) | 2.78642457 |
| 121 | ubiquinone biosynthetic process (GO:0006744) | 2.78642457 |
| 122 | negative regulation of interleukin-6 production (GO:0032715) | 2.78369676 |
| 123 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.77560229 |
| 124 | amino acid salvage (GO:0043102) | 2.77152944 |
| 125 | L-methionine salvage (GO:0071267) | 2.77152944 |
| 126 | L-methionine biosynthetic process (GO:0071265) | 2.77152944 |
| 127 | protein localization to mitochondrion (GO:0070585) | 2.76392000 |
| 128 | response to host immune response (GO:0052572) | 2.74177204 |
| 129 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.74177204 |
| 130 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 2.74055756 |
| 131 | presynaptic membrane organization (GO:0097090) | 2.73093218 |
| 132 | superoxide anion generation (GO:0042554) | 2.72748345 |
| 133 | tolerance induction (GO:0002507) | 2.70963897 |
| 134 | organelle membrane fusion (GO:0090174) | 2.70870987 |
| 135 | presynaptic membrane assembly (GO:0097105) | 2.70029248 |
| 136 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.68796355 |
| 137 | detection of external biotic stimulus (GO:0098581) | 2.67854454 |
| 138 | positive regulation of antigen processing and presentation (GO:0002579) | 2.67554724 |
| 139 | phagosome maturation (GO:0090382) | 2.66510622 |
| 140 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.66365064 |
| 141 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.66084617 |
| 142 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.65476076 |
| 143 | myeloid cell development (GO:0061515) | 2.64342692 |
| 144 | neuronal action potential propagation (GO:0019227) | 2.64230683 |
| 145 | cullin deneddylation (GO:0010388) | 2.63980632 |
| 146 | erythrocyte development (GO:0048821) | 2.63825229 |
| 147 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.63399494 |
| 148 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.63399494 |
| 149 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.63399494 |
| 150 | positive regulation of mitochondrial fission (GO:0090141) | 2.61735562 |
| 151 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.60392860 |
| 152 | leukocyte aggregation (GO:0070486) | 2.58908439 |
| 153 | DNA deamination (GO:0045006) | 2.56989341 |
| 154 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.56821894 |
| 155 | megakaryocyte development (GO:0035855) | 2.55903880 |
| 156 | regulation of regulated secretory pathway (GO:1903305) | 2.55531210 |
| 157 | porphyrin-containing compound biosynthetic process (GO:0006779) | 2.55471127 |
| 158 | mitochondrion morphogenesis (GO:0070584) | 2.55465852 |
| 159 | negative regulation of T cell mediated immunity (GO:0002710) | 2.55195176 |
| 160 | mast cell activation (GO:0045576) | 2.54570904 |
| 161 | positive thymic T cell selection (GO:0045059) | 2.53840165 |
| 162 | respiratory burst (GO:0045730) | 2.53700559 |
| 163 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.53344996 |
| 164 | positive regulation of B cell differentiation (GO:0045579) | 2.53146417 |
| 165 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.53108128 |
| 166 | regulation of antigen processing and presentation (GO:0002577) | 2.52158920 |
| 167 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.51814690 |
| 168 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.51814690 |
| 169 | hemoglobin metabolic process (GO:0020027) | 2.50855636 |
| 170 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.50850848 |
| 171 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.50850848 |
| 172 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.50663327 |
| 173 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.50417135 |
| 174 | ubiquinone metabolic process (GO:0006743) | 2.50306696 |
| 175 | regulation of memory T cell differentiation (GO:0043380) | 2.48791079 |
| 176 | B cell receptor signaling pathway (GO:0050853) | 2.46521625 |
| 177 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.46382588 |
| 178 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.46382588 |
| 179 | rRNA methylation (GO:0031167) | 2.46328707 |
| 180 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.46072074 |
| 181 | erythrocyte maturation (GO:0043249) | 2.46061330 |
| 182 | regulation of platelet activation (GO:0010543) | 2.46038994 |
| 183 | response to type I interferon (GO:0034340) | 2.45232834 |
| 184 | regulation of regulatory T cell differentiation (GO:0045589) | 2.44612038 |
| 185 | regulation of cellular amine metabolic process (GO:0033238) | 2.44076057 |
| 186 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.43557092 |
| 187 | neurotransmitter uptake (GO:0001504) | 2.43132960 |
| 188 | vocalization behavior (GO:0071625) | 2.42625135 |
| 189 | regulation of water loss via skin (GO:0033561) | 2.42011336 |
| 190 | detection of molecule of bacterial origin (GO:0032490) | 2.41709639 |
| 191 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.41561273 |
| 192 | porphyrin-containing compound metabolic process (GO:0006778) | 2.41551496 |
| 193 | mitochondrial transport (GO:0006839) | 2.41284967 |
| 194 | B cell mediated immunity (GO:0019724) | 2.41030964 |
| 195 | negative regulation of phagocytosis (GO:0050765) | 2.40216042 |
| 196 | type I interferon signaling pathway (GO:0060337) | 2.39034313 |
| 197 | cellular response to type I interferon (GO:0071357) | 2.39034313 |
| 198 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.39008029 |
| 199 | hepatocyte apoptotic process (GO:0097284) | 2.37386239 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.11527909 |
| 2 | GATA1_22025678_ChIP-Seq_K562_Human | 4.22519107 |
| 3 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.77296058 |
| 4 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.73443964 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.71981712 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.61195880 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.29018471 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21129007 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14856943 |
| 10 | GATA1_19941826_ChIP-Seq_K562_Human | 3.05657489 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.02986727 |
| 12 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02666394 |
| 13 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 3.02171199 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.98201880 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.96882320 |
| 16 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.96292244 |
| 17 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.74886782 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.71820750 |
| 19 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.71591789 |
| 20 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.56879541 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.54433686 |
| 22 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45368793 |
| 23 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.45330056 |
| 24 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.43232984 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.38917740 |
| 26 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.32228536 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.31387783 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30932019 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.27923889 |
| 30 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24192874 |
| 31 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.23764486 |
| 32 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.18585202 |
| 33 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.18422601 |
| 34 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.18369070 |
| 35 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.17428761 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 2.13101805 |
| 37 | GATA2_19941826_ChIP-Seq_K562_Human | 2.11634760 |
| 38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.10822716 |
| 39 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.05644122 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.03311546 |
| 41 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.01349623 |
| 42 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.99515706 |
| 43 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.97894267 |
| 44 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.94982332 |
| 45 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.93905256 |
| 46 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91510517 |
| 47 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.82322142 |
| 48 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.79619382 |
| 49 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.79199170 |
| 50 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.76453801 |
| 51 | MYB_26560356_Chip-Seq_TH2_Human | 1.75963914 |
| 52 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.75437465 |
| 53 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.72277159 |
| 54 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.71866484 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71839704 |
| 56 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.69776857 |
| 57 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.68961142 |
| 58 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.66799109 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.64735795 |
| 60 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63814587 |
| 61 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.63594796 |
| 62 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.62994587 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.62880627 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59628109 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.59586580 |
| 66 | GATA3_26560356_Chip-Seq_TH2_Human | 1.59127143 |
| 67 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58678611 |
| 68 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.54976430 |
| 69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.54006771 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53395292 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.52043898 |
| 72 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.49711541 |
| 73 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.49665473 |
| 74 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.49656968 |
| 75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49297533 |
| 76 | MYB_26560356_Chip-Seq_TH1_Human | 1.48851379 |
| 77 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.48072505 |
| 78 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46496027 |
| 79 | MAF_26560356_Chip-Seq_TH1_Human | 1.46454996 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46213551 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44955996 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44776668 |
| 83 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.44192354 |
| 84 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.43648747 |
| 85 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.43483215 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.42541333 |
| 87 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.40461254 |
| 88 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37093579 |
| 89 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.36033163 |
| 90 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.32931230 |
| 91 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.32203519 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.31979116 |
| 93 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.31677013 |
| 94 | FUS_26573619_Chip-Seq_HEK293_Human | 1.31523809 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.31189650 |
| 96 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30583566 |
| 97 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.30125546 |
| 98 | P300_19829295_ChIP-Seq_ESCs_Human | 1.29075798 |
| 99 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.28640993 |
| 100 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.28095880 |
| 101 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.27798764 |
| 102 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.27619685 |
| 103 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27242027 |
| 104 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.26228589 |
| 105 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.25350900 |
| 106 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.23873046 |
| 107 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.21581555 |
| 108 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.21276268 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.21102980 |
| 110 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.19726079 |
| 111 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19344679 |
| 112 | P300_27268052_Chip-Seq_Bcells_Human | 1.18945502 |
| 113 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.18361504 |
| 114 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.18204577 |
| 115 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16658745 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16624499 |
| 117 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.16607014 |
| 118 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.15063243 |
| 119 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14960755 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14858699 |
| 121 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.14719597 |
| 122 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.14612105 |
| 123 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.14605582 |
| 124 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.14586214 |
| 125 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.14412980 |
| 126 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.14358352 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.13884330 |
| 128 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.13836647 |
| 129 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13520039 |
| 130 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.13438183 |
| 131 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.13292114 |
| 132 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13261396 |
| 133 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.13228969 |
| 134 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.13093082 |
| 135 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12254552 |
| 136 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.12138837 |
| 137 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.12066451 |
| 138 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.09597841 |
| 139 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.09393936 |
| 140 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09188716 |
| 141 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.09164539 |
| 142 | MAF_26560356_Chip-Seq_TH2_Human | 1.08921596 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.08783753 |
| 144 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.07338393 |
| 145 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07057153 |
| 146 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.06062745 |
| 147 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.05992370 |
| 148 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.05923124 |
| 149 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.05710294 |
| 150 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.04948484 |
| 151 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.04843392 |
| 152 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04597456 |
| 153 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.03655445 |
| 154 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.03270234 |
| 155 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.02822204 |
| 156 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.02187907 |
| 157 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.02051434 |
| 158 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.02013340 |
| 159 | ERA_21632823_ChIP-Seq_H3396_Human | 1.01791095 |
| 160 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.01760508 |
| 161 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.01550245 |
| 162 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.00948620 |
| 163 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00139859 |
| 164 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.00095203 |
| 165 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.00082959 |
| 166 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.00042224 |
| 167 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.99820522 |
| 168 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.98252088 |
| 169 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.98104482 |
| 170 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.97727952 |
| 171 | P68_20966046_ChIP-Seq_HELA_Human | 0.97477061 |
| 172 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97471532 |
| 173 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.96521332 |
| 174 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.94738629 |
| 175 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.94241459 |
| 176 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.94020529 |
| 177 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.93303159 |
| 178 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.92893129 |
| 179 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.92392541 |
| 180 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90741500 |
| 181 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.90510679 |
| 182 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90508717 |
| 183 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.90460363 |
| 184 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.90460363 |
| 185 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90436018 |
| 186 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.90328233 |
| 187 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.89796302 |
| 188 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.89542091 |
| 189 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.89290525 |
| 190 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.88522269 |
| 191 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.88367413 |
| 192 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.88045728 |
| 193 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87702676 |
| 194 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.87071074 |
| 195 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.87071074 |
| 196 | EWS_26573619_Chip-Seq_HEK293_Human | 0.86828295 |
| 197 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.86000835 |
| 198 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.83950056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.15560127 |
| 2 | MP0003724_increased_susceptibility_to | 3.43508171 |
| 3 | MP0005464_abnormal_platelet_physiology | 3.16324962 |
| 4 | MP0001529_abnormal_vocalization | 3.01901874 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.87541946 |
| 6 | MP0003656_abnormal_erythrocyte_physiolo | 2.80733895 |
| 7 | MP0003436_decreased_susceptibility_to | 2.76641059 |
| 8 | MP0009046_muscle_twitch | 2.66204699 |
| 9 | MP0002837_dystrophic_cardiac_calcinosis | 2.64317077 |
| 10 | MP0003172_abnormal_lysosome_physiology | 2.63589325 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.59575577 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.53712670 |
| 13 | MP0001986_abnormal_taste_sensitivity | 2.51522889 |
| 14 | MP0005671_abnormal_response_to | 2.51511311 |
| 15 | MP0003303_peritoneal_inflammation | 2.49226584 |
| 16 | MP0004142_abnormal_muscle_tone | 2.46607562 |
| 17 | MP0002876_abnormal_thyroid_physiology | 2.43345427 |
| 18 | MP0002735_abnormal_chemical_nociception | 2.40348083 |
| 19 | MP0003646_muscle_fatigue | 2.39739469 |
| 20 | MP0009745_abnormal_behavioral_response | 2.39662474 |
| 21 | MP0002419_abnormal_innate_immunity | 2.38113160 |
| 22 | MP0000685_abnormal_immune_system | 2.35897657 |
| 23 | MP0006082_CNS_inflammation | 2.31986050 |
| 24 | MP0005025_abnormal_response_to | 2.24484635 |
| 25 | MP0002272_abnormal_nervous_system | 2.24099054 |
| 26 | MP0001905_abnormal_dopamine_level | 2.23824806 |
| 27 | MP0001968_abnormal_touch/_nociception | 2.22962494 |
| 28 | MP0003635_abnormal_synaptic_transmissio | 2.21267116 |
| 29 | MP0002064_seizures | 2.21262901 |
| 30 | MP0009785_altered_susceptibility_to | 2.21175272 |
| 31 | MP0005058_abnormal_lysosome_morphology | 2.20611426 |
| 32 | MP0001188_hyperpigmentation | 2.17209552 |
| 33 | MP0005000_abnormal_immune_tolerance | 2.16430482 |
| 34 | MP0002736_abnormal_nociception_after | 2.16147591 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 2.15134540 |
| 36 | MP0000015_abnormal_ear_pigmentation | 2.09183516 |
| 37 | MP0003941_abnormal_skin_development | 2.09140789 |
| 38 | MP0005387_immune_system_phenotype | 2.08684258 |
| 39 | MP0001790_abnormal_immune_system | 2.08684258 |
| 40 | MP0001800_abnormal_humoral_immune | 2.08553262 |
| 41 | MP0002148_abnormal_hypersensitivity_rea | 2.07940693 |
| 42 | MP0005451_abnormal_body_composition | 2.01553802 |
| 43 | MP0002723_abnormal_immune_serum | 1.98265813 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.94268760 |
| 45 | MP0003718_maternal_effect | 1.94149196 |
| 46 | MP0002734_abnormal_mechanical_nocicepti | 1.92688512 |
| 47 | MP0006035_abnormal_mitochondrial_morpho | 1.91379587 |
| 48 | MP0001486_abnormal_startle_reflex | 1.90022284 |
| 49 | MP0002420_abnormal_adaptive_immunity | 1.89486706 |
| 50 | MP0001819_abnormal_immune_cell | 1.88528289 |
| 51 | MP0005083_abnormal_biliary_tract | 1.83766986 |
| 52 | MP0004147_increased_porphyrin_level | 1.82855368 |
| 53 | MP0002572_abnormal_emotion/affect_behav | 1.79498535 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.77323334 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.77323334 |
| 56 | MP0002132_abnormal_respiratory_system | 1.76810690 |
| 57 | MP0004215_abnormal_myocardial_fiber | 1.76098004 |
| 58 | MP0009764_decreased_sensitivity_to | 1.75905004 |
| 59 | MP0004270_analgesia | 1.72879939 |
| 60 | MP0002063_abnormal_learning/memory/cond | 1.70451342 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.68448720 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.68250797 |
| 63 | MP0005167_abnormal_blood-brain_barrier | 1.64712881 |
| 64 | MP0002067_abnormal_sensory_capabilities | 1.63417520 |
| 65 | MP0008877_abnormal_DNA_methylation | 1.62551648 |
| 66 | MP0002822_catalepsy | 1.61882880 |
| 67 | MP0000751_myopathy | 1.59717646 |
| 68 | MP0005075_abnormal_melanosome_morpholog | 1.58208908 |
| 69 | MP0005171_absent_coat_pigmentation | 1.58139066 |
| 70 | MP0001970_abnormal_pain_threshold | 1.56275940 |
| 71 | MP0009840_abnormal_foam_cell | 1.56224475 |
| 72 | MP0001533_abnormal_skeleton_physiology | 1.55345401 |
| 73 | MP0005386_behavior/neurological_phenoty | 1.53096525 |
| 74 | MP0004924_abnormal_behavior | 1.53096525 |
| 75 | MP0006292_abnormal_olfactory_placode | 1.48216373 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.47186037 |
| 77 | MP0002398_abnormal_bone_marrow | 1.45711718 |
| 78 | MP0009278_abnormal_bone_marrow | 1.44773321 |
| 79 | MP0001845_abnormal_inflammatory_respons | 1.42366706 |
| 80 | MP0002405_respiratory_system_inflammati | 1.40737902 |
| 81 | MP0002638_abnormal_pupillary_reflex | 1.38061724 |
| 82 | MP0000716_abnormal_immune_system | 1.36910218 |
| 83 | MP0005409_darkened_coat_color | 1.36678045 |
| 84 | MP0002733_abnormal_thermal_nociception | 1.36546163 |
| 85 | MP0005174_abnormal_tail_pigmentation | 1.35555703 |
| 86 | MP0000343_altered_response_to | 1.35490255 |
| 87 | MP0004381_abnormal_hair_follicle | 1.34023277 |
| 88 | MP0000566_synostosis | 1.33901163 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 1.32779757 |
| 90 | MP0003879_abnormal_hair_cell | 1.31771684 |
| 91 | MP0002184_abnormal_innervation | 1.30948611 |
| 92 | MP0000689_abnormal_spleen_morphology | 1.30883732 |
| 93 | MP0000569_abnormal_digit_pigmentation | 1.30806318 |
| 94 | MP0008260_abnormal_autophagy | 1.29619906 |
| 95 | MP0005310_abnormal_salivary_gland | 1.29396188 |
| 96 | MP0009379_abnormal_foot_pigmentation | 1.26848609 |
| 97 | MP0005646_abnormal_pituitary_gland | 1.26016867 |
| 98 | MP0009333_abnormal_splenocyte_physiolog | 1.25961583 |
| 99 | MP0001984_abnormal_olfaction | 1.25955421 |
| 100 | MP0003137_abnormal_impulse_conducting | 1.25893060 |
| 101 | MP0002160_abnormal_reproductive_system | 1.25750712 |
| 102 | MP0003191_abnormal_cellular_cholesterol | 1.22764598 |
| 103 | MP0010386_abnormal_urinary_bladder | 1.22665443 |
| 104 | MP0002102_abnormal_ear_morphology | 1.22572920 |
| 105 | MP0002277_abnormal_respiratory_mucosa | 1.21811240 |
| 106 | MP0002429_abnormal_blood_cell | 1.19472897 |
| 107 | MP0002722_abnormal_immune_system | 1.18680317 |
| 108 | MP0008469_abnormal_protein_level | 1.17460729 |
| 109 | MP0003763_abnormal_thymus_physiology | 1.17444577 |
| 110 | MP0002332_abnormal_exercise_endurance | 1.16676831 |
| 111 | MP0003300_gastrointestinal_ulcer | 1.15825528 |
| 112 | MP0003866_abnormal_defecation | 1.15066627 |
| 113 | MP0004130_abnormal_muscle_cell | 1.14459325 |
| 114 | MP0004510_myositis | 1.14143586 |
| 115 | MP0008058_abnormal_DNA_repair | 1.13646840 |
| 116 | MP0002557_abnormal_social/conspecific_i | 1.11620258 |
| 117 | MP0010155_abnormal_intestine_physiology | 1.10300236 |
| 118 | MP0008872_abnormal_physiological_respon | 1.08660341 |
| 119 | MP0003136_yellow_coat_color | 1.04868369 |
| 120 | MP0004947_skin_inflammation | 1.04526996 |
| 121 | MP0003075_altered_response_to | 1.03518391 |
| 122 | MP0008004_abnormal_stomach_pH | 1.03227072 |
| 123 | MP0000749_muscle_degeneration | 1.02471800 |
| 124 | MP0002138_abnormal_hepatobiliary_system | 1.02133895 |
| 125 | MP0005645_abnormal_hypothalamus_physiol | 1.02019321 |
| 126 | MP0003828_pulmonary_edema | 1.01992446 |
| 127 | MP0009697_abnormal_copulation | 1.01034821 |
| 128 | MP0002163_abnormal_gland_morphology | 1.00994843 |
| 129 | MP0005551_abnormal_eye_electrophysiolog | 1.00458182 |
| 130 | MP0001663_abnormal_digestive_system | 0.99963530 |
| 131 | MP0002796_impaired_skin_barrier | 0.99498860 |
| 132 | MP0004145_abnormal_muscle_electrophysio | 0.98179424 |
| 133 | MP0003045_fibrosis | 0.97309260 |
| 134 | MP0002066_abnormal_motor_capabilities/c | 0.96765187 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.96321159 |
| 136 | MP0002229_neurodegeneration | 0.94995816 |
| 137 | MP0005330_cardiomyopathy | 0.92822970 |
| 138 | MP0003195_calcinosis | 0.92284128 |
| 139 | MP0001485_abnormal_pinna_reflex | 0.92176843 |
| 140 | MP0008057_abnormal_DNA_replication | 0.91635846 |
| 141 | MP0001873_stomach_inflammation | 0.91108615 |
| 142 | MP0004036_abnormal_muscle_relaxation | 0.91071430 |
| 143 | MP0002752_abnormal_somatic_nervous | 0.90490231 |
| 144 | MP0001963_abnormal_hearing_physiology | 0.90109974 |
| 145 | MP0000372_irregular_coat_pigmentation | 0.88380231 |
| 146 | MP0009763_increased_sensitivity_to | 0.87756919 |
| 147 | MP0004043_abnormal_pH_regulation | 0.87617717 |
| 148 | MP0000778_abnormal_nervous_system | 0.87401034 |
| 149 | MP0004883_abnormal_blood_vessel | 0.86861710 |
| 150 | MP0002095_abnormal_skin_pigmentation | 0.86793996 |
| 151 | MP0003329_amyloid_beta_deposits | 0.85609185 |
| 152 | MP0005379_endocrine/exocrine_gland_phen | 0.85060590 |
| 153 | MP0002882_abnormal_neuron_morphology | 0.84432585 |
| 154 | MP0002693_abnormal_pancreas_physiology | 0.84217241 |
| 155 | MP0004085_abnormal_heartbeat | 0.84128626 |
| 156 | MP0004742_abnormal_vestibular_system | 0.83726664 |
| 157 | MP0001851_eye_inflammation | 0.83477381 |
| 158 | MP0004484_altered_response_of | 0.83319560 |
| 159 | MP0003878_abnormal_ear_physiology | 0.83235475 |
| 160 | MP0005377_hearing/vestibular/ear_phenot | 0.83235475 |
| 161 | MP0000955_abnormal_spinal_cord | 0.81922000 |
| 162 | MP0001764_abnormal_homeostasis | 0.81665516 |
| 163 | MP0000371_diluted_coat_color | 0.81388985 |
| 164 | MP0003011_delayed_dark_adaptation | 0.80733171 |
| 165 | MP0003806_abnormal_nucleotide_metabolis | 0.80033020 |
| 166 | MP0008569_lethality_at_weaning | 0.78678426 |
| 167 | MP0005266_abnormal_metabolism | 0.77961771 |
| 168 | MP0000858_altered_metastatic_potential | 0.77201420 |
| 169 | MP0008875_abnormal_xenobiotic_pharmacok | 0.76507637 |
| 170 | MP0008775_abnormal_heart_ventricle | 0.76115712 |
| 171 | MP0000703_abnormal_thymus_morphology | 0.75976574 |
| 172 | MP0002998_abnormal_bone_remodeling | 0.74046959 |
| 173 | MP0005389_reproductive_system_phenotype | 0.73828616 |
| 174 | MP0006054_spinal_hemorrhage | 0.73028737 |
| 175 | MP0000249_abnormal_blood_vessel | 0.72698082 |
| 176 | MP0005164_abnormal_response_to | 0.72004322 |
| 177 | MP0004084_abnormal_cardiac_muscle | 0.71085970 |
| 178 | MP0001502_abnormal_circadian_rhythm | 0.71071461 |
| 179 | MP0002751_abnormal_autonomic_nervous | 0.70771707 |
| 180 | MP0003786_premature_aging | 0.68727509 |
| 181 | MP0005620_abnormal_muscle_contractility | 0.67959923 |
| 182 | MP0010329_abnormal_lipoprotein_level | 0.67392767 |
| 183 | MP0008874_decreased_physiological_sensi | 0.66002459 |
| 184 | MP0000604_amyloidosis | 0.65734228 |
| 185 | MP0000230_abnormal_systemic_arterial | 0.64474672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 5.83804937 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.36065414 |
| 3 | Mitochondrial inheritance (HP:0001427) | 5.16784650 |
| 4 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 5.04181922 |
| 5 | Progressive macrocephaly (HP:0004481) | 4.83085067 |
| 6 | Acute encephalopathy (HP:0006846) | 4.69085750 |
| 7 | Progressive external ophthalmoplegia (HP:0000590) | 4.62038770 |
| 8 | Prolonged bleeding time (HP:0003010) | 4.60933001 |
| 9 | Hepatocellular necrosis (HP:0001404) | 4.52624777 |
| 10 | Hypochromic microcytic anemia (HP:0004840) | 4.51795887 |
| 11 | Increased CSF lactate (HP:0002490) | 4.47954026 |
| 12 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 4.34067450 |
| 13 | Petechiae (HP:0000967) | 4.30562842 |
| 14 | Stomatitis (HP:0010280) | 4.23540787 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.00901503 |
| 16 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.00901503 |
| 17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.00901503 |
| 18 | Recurrent bacterial skin infections (HP:0005406) | 3.97992776 |
| 19 | Hepatic necrosis (HP:0002605) | 3.95401289 |
| 20 | Recurrent abscess formation (HP:0002722) | 3.91389843 |
| 21 | Abnormality of macrophages (HP:0004311) | 3.84681389 |
| 22 | Increased hepatocellular lipid droplets (HP:0006565) | 3.79487696 |
| 23 | Eczematoid dermatitis (HP:0000976) | 3.75624626 |
| 24 | Renal Fanconi syndrome (HP:0001994) | 3.64691769 |
| 25 | Exercise intolerance (HP:0003546) | 3.62435224 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.56861188 |
| 27 | Poikilocytosis (HP:0004447) | 3.53046242 |
| 28 | Myositis (HP:0100614) | 3.50590571 |
| 29 | Hypochromic anemia (HP:0001931) | 3.50174202 |
| 30 | Increased cerebral lipofuscin (HP:0011813) | 3.49330105 |
| 31 | Cerebral edema (HP:0002181) | 3.48228744 |
| 32 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.46145711 |
| 33 | Increased intramyocellular lipid droplets (HP:0012240) | 3.43828645 |
| 34 | Lactic acidosis (HP:0003128) | 3.43187269 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 3.42384470 |
| 36 | Epistaxis (HP:0000421) | 3.39194262 |
| 37 | Increased serum lactate (HP:0002151) | 3.30790444 |
| 38 | 3-Methylglutaconic aciduria (HP:0003535) | 3.27693741 |
| 39 | Microcytic anemia (HP:0001935) | 3.26678267 |
| 40 | Optic disc pallor (HP:0000543) | 3.23301299 |
| 41 | Recurrent fungal infections (HP:0002841) | 3.15260130 |
| 42 | Purpura (HP:0000979) | 3.15163122 |
| 43 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.12760119 |
| 44 | Respiratory failure (HP:0002878) | 3.11620466 |
| 45 | Pustule (HP:0200039) | 3.10570856 |
| 46 | Orchitis (HP:0100796) | 3.09076393 |
| 47 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.08084789 |
| 48 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.08084789 |
| 49 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07161734 |
| 50 | Abnormality of iron homeostasis (HP:0011031) | 3.05409760 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 3.01415132 |
| 52 | Obstructive lung disease (HP:0006536) | 3.01415132 |
| 53 | Focal motor seizures (HP:0011153) | 3.00969265 |
| 54 | Abnormal hemoglobin (HP:0011902) | 2.95670816 |
| 55 | Retrobulbar optic neuritis (HP:0100654) | 2.95627755 |
| 56 | Optic neuritis (HP:0100653) | 2.95627755 |
| 57 | Gastrointestinal infarctions (HP:0005244) | 2.95021773 |
| 58 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.94572015 |
| 59 | Increased muscle lipid content (HP:0009058) | 2.85897890 |
| 60 | Albinism (HP:0001022) | 2.85213842 |
| 61 | Polycythemia (HP:0001901) | 2.79608845 |
| 62 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.79551027 |
| 63 | Recurrent cutaneous fungal infections (HP:0011370) | 2.79551027 |
| 64 | Increased serum ferritin (HP:0003281) | 2.78718288 |
| 65 | Microvesicular hepatic steatosis (HP:0001414) | 2.77126377 |
| 66 | Gingival bleeding (HP:0000225) | 2.76983704 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.76218419 |
| 68 | Abnormal hair whorl (HP:0010721) | 2.71522567 |
| 69 | Recurrent skin infections (HP:0001581) | 2.71103806 |
| 70 | Leukodystrophy (HP:0002415) | 2.70530659 |
| 71 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.69468223 |
| 72 | Encephalitis (HP:0002383) | 2.68915413 |
| 73 | Vacuolated lymphocytes (HP:0001922) | 2.68603746 |
| 74 | Febrile seizures (HP:0002373) | 2.65472442 |
| 75 | Dysostosis multiplex (HP:0000943) | 2.65202994 |
| 76 | Exertional dyspnea (HP:0002875) | 2.65048733 |
| 77 | Duplicated collecting system (HP:0000081) | 2.65009664 |
| 78 | Hypothermia (HP:0002045) | 2.62301317 |
| 79 | Autoimmune thrombocytopenia (HP:0001973) | 2.56906017 |
| 80 | Proximal tubulopathy (HP:0000114) | 2.55793586 |
| 81 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.53143352 |
| 82 | Increased serum pyruvate (HP:0003542) | 2.53012822 |
| 83 | Abnormality of glycolysis (HP:0004366) | 2.53012822 |
| 84 | Abnormality of renal resorption (HP:0011038) | 2.52608804 |
| 85 | External ophthalmoplegia (HP:0000544) | 2.49541618 |
| 86 | Episodic fever (HP:0001954) | 2.45445458 |
| 87 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.43145705 |
| 88 | Myokymia (HP:0002411) | 2.41214593 |
| 89 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.38378169 |
| 90 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.38378169 |
| 91 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.38378169 |
| 92 | Meningitis (HP:0001287) | 2.33161223 |
| 93 | Abnormality of the renal collecting system (HP:0004742) | 2.31873359 |
| 94 | Abnormal platelet volume (HP:0011876) | 2.31388245 |
| 95 | Abnormality of T cell physiology (HP:0011840) | 2.29731247 |
| 96 | Birth length less than 3rd percentile (HP:0003561) | 2.29625123 |
| 97 | Respiratory difficulties (HP:0002880) | 2.29608928 |
| 98 | Increased IgM level (HP:0003496) | 2.28397765 |
| 99 | Menorrhagia (HP:0000132) | 2.27522497 |
| 100 | Keratoconjunctivitis (HP:0001096) | 2.25487980 |
| 101 | Anorexia (HP:0002039) | 2.24968518 |
| 102 | Reticulocytosis (HP:0001923) | 2.23241266 |
| 103 | Urticaria (HP:0001025) | 2.22969052 |
| 104 | Mediastinal lymphadenopathy (HP:0100721) | 2.22063773 |
| 105 | Poor suck (HP:0002033) | 2.20480963 |
| 106 | Vasculitis (HP:0002633) | 2.20338660 |
| 107 | Neuroendocrine neoplasm (HP:0100634) | 2.18610597 |
| 108 | Chronic otitis media (HP:0000389) | 2.16470763 |
| 109 | Atonic seizures (HP:0010819) | 2.15645095 |
| 110 | Granulocytopenia (HP:0001913) | 2.15436482 |
| 111 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.14385315 |
| 112 | Paralysis (HP:0003470) | 2.13458488 |
| 113 | Nasal polyposis (HP:0100582) | 2.13323573 |
| 114 | Clumsiness (HP:0002312) | 2.12816496 |
| 115 | Cerebral hypomyelination (HP:0006808) | 2.12628613 |
| 116 | Impaired platelet aggregation (HP:0003540) | 2.11939236 |
| 117 | Abnormal platelet function (HP:0011869) | 2.11939236 |
| 118 | Pulmonary infiltrates (HP:0002113) | 2.10098186 |
| 119 | Abnormality of T cells (HP:0002843) | 2.09689232 |
| 120 | Keratoconjunctivitis sicca (HP:0001097) | 2.09283911 |
| 121 | Epileptic encephalopathy (HP:0200134) | 2.09054031 |
| 122 | Hemoptysis (HP:0002105) | 2.08254209 |
| 123 | Pheochromocytoma (HP:0002666) | 2.07707780 |
| 124 | Abnormality of the nasal mucosa (HP:0000433) | 2.07045123 |
| 125 | CNS demyelination (HP:0007305) | 2.06880830 |
| 126 | Leukocytosis (HP:0001974) | 2.06666607 |
| 127 | Ventricular fibrillation (HP:0001663) | 2.06066487 |
| 128 | Parakeratosis (HP:0001036) | 2.03934342 |
| 129 | Ocular albinism (HP:0001107) | 2.02808093 |
| 130 | Breast hypoplasia (HP:0003187) | 2.02309678 |
| 131 | Lethargy (HP:0001254) | 2.01751407 |
| 132 | Medial flaring of the eyebrow (HP:0010747) | 2.01615327 |
| 133 | Unsteady gait (HP:0002317) | 1.99920183 |
| 134 | Fetal akinesia sequence (HP:0001989) | 1.99185750 |
| 135 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.97874053 |
| 136 | Mucopolysacchariduria (HP:0008155) | 1.97874053 |
| 137 | Type 2 muscle fiber atrophy (HP:0003554) | 1.97213192 |
| 138 | X-linked dominant inheritance (HP:0001423) | 1.96648019 |
| 139 | Autoimmune hemolytic anemia (HP:0001890) | 1.96289121 |
| 140 | Panhypogammaglobulinemia (HP:0003139) | 1.96223059 |
| 141 | Emotional lability (HP:0000712) | 1.96147902 |
| 142 | Broad-based gait (HP:0002136) | 1.95223928 |
| 143 | Hyperphosphaturia (HP:0003109) | 1.95178741 |
| 144 | Hypertensive crisis (HP:0100735) | 1.94483515 |
| 145 | Renal tubular dysfunction (HP:0000124) | 1.94377984 |
| 146 | Osteomalacia (HP:0002749) | 1.94270733 |
| 147 | Increased mean platelet volume (HP:0011877) | 1.93584485 |
| 148 | Chest pain (HP:0100749) | 1.93511718 |
| 149 | Vertigo (HP:0002321) | 1.93135683 |
| 150 | Acanthocytosis (HP:0001927) | 1.93081714 |
| 151 | Eosinophilia (HP:0001880) | 1.92147995 |
| 152 | Palpitations (HP:0001962) | 1.91207326 |
| 153 | Cholelithiasis (HP:0001081) | 1.91070917 |
| 154 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.90626189 |
| 155 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.88417176 |
| 156 | Hematochezia (HP:0002573) | 1.88263011 |
| 157 | Increased IgE level (HP:0003212) | 1.87158639 |
| 158 | Gingivitis (HP:0000230) | 1.86995825 |
| 159 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86880028 |
| 160 | Joint swelling (HP:0001386) | 1.86525097 |
| 161 | Calf muscle hypertrophy (HP:0008981) | 1.84290389 |
| 162 | Limb dystonia (HP:0002451) | 1.84185494 |
| 163 | Loss of speech (HP:0002371) | 1.84097006 |
| 164 | Congenital stationary night blindness (HP:0007642) | 1.84025958 |
| 165 | Hyperlipoproteinemia (HP:0010980) | 1.83199896 |
| 166 | Acne (HP:0001061) | 1.83094181 |
| 167 | Hepatosplenomegaly (HP:0001433) | 1.82913465 |
| 168 | Glycosuria (HP:0003076) | 1.80153111 |
| 169 | Abnormality of urine glucose concentration (HP:0011016) | 1.80153111 |
| 170 | Inability to walk (HP:0002540) | 1.77114384 |
| 171 | Hyperventilation (HP:0002883) | 1.75755160 |
| 172 | Chromsome breakage (HP:0040012) | 1.75690556 |
| 173 | Nephrogenic diabetes insipidus (HP:0009806) | 1.75345066 |
| 174 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.74221025 |
| 175 | Long foot (HP:0001833) | 1.73470604 |
| 176 | Abnormality of alanine metabolism (HP:0010916) | 1.73359334 |
| 177 | Hyperalaninemia (HP:0003348) | 1.73359334 |
| 178 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73359334 |
| 179 | Anxiety (HP:0000739) | 1.73094424 |
| 180 | Sudden death (HP:0001699) | 1.72109135 |
| 181 | Delusions (HP:0000746) | 1.72089775 |
| 182 | Absence seizures (HP:0002121) | 1.67171885 |
| 183 | Gait imbalance (HP:0002141) | 1.64993046 |
| 184 | Focal seizures (HP:0007359) | 1.64946367 |
| 185 | Progressive inability to walk (HP:0002505) | 1.64707376 |
| 186 | Abnormal pupillary function (HP:0007686) | 1.63043484 |
| 187 | Abnormal urine phosphate concentration (HP:0012599) | 1.62807444 |
| 188 | Methylmalonic aciduria (HP:0012120) | 1.62704033 |
| 189 | Azoospermia (HP:0000027) | 1.62187406 |
| 190 | Testicular atrophy (HP:0000029) | 1.61836138 |
| 191 | Dialeptic seizures (HP:0011146) | 1.59862230 |
| 192 | Congenital primary aphakia (HP:0007707) | 1.57735541 |
| 193 | Areflexia of lower limbs (HP:0002522) | 1.56396634 |
| 194 | Stomach cancer (HP:0012126) | 1.56144723 |
| 195 | Methylmalonic acidemia (HP:0002912) | 1.55075896 |
| 196 | Generalized tonic-clonic seizures (HP:0002069) | 1.54675476 |
| 197 | Pancreatic fibrosis (HP:0100732) | 1.54421033 |
| 198 | Blindness (HP:0000618) | 1.54121673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 4.94232265 |
| 2 | RIPK4 | 4.46749896 |
| 3 | STK16 | 3.74790894 |
| 4 | MARK1 | 3.48531185 |
| 5 | ZAK | 3.14019746 |
| 6 | PLK4 | 3.00805284 |
| 7 | TAOK3 | 2.98210157 |
| 8 | CASK | 2.88574301 |
| 9 | BLK | 2.88070522 |
| 10 | MAP4K1 | 2.72315077 |
| 11 | MAP3K12 | 2.62397730 |
| 12 | IRAK4 | 2.57139097 |
| 13 | FRK | 2.50954631 |
| 14 | GRK6 | 2.31617447 |
| 15 | MAP2K7 | 2.30487794 |
| 16 | MAP2K3 | 2.24188970 |
| 17 | SYK | 2.13044885 |
| 18 | MAP3K11 | 2.08626116 |
| 19 | IRAK2 | 2.03975048 |
| 20 | GRK7 | 1.99947353 |
| 21 | MAP3K13 | 1.99915671 |
| 22 | BUB1 | 1.99623015 |
| 23 | NME1 | 1.93487748 |
| 24 | BTK | 1.90912237 |
| 25 | ZAP70 | 1.82700838 |
| 26 | PTK2B | 1.81039610 |
| 27 | FES | 1.80298398 |
| 28 | PINK1 | 1.72368878 |
| 29 | TYK2 | 1.71105930 |
| 30 | IRAK1 | 1.65809722 |
| 31 | TNIK | 1.63409466 |
| 32 | ACVR1B | 1.62538985 |
| 33 | IKBKB | 1.57907187 |
| 34 | MAP3K3 | 1.56431510 |
| 35 | ERN1 | 1.55644149 |
| 36 | SIK2 | 1.45675147 |
| 37 | TEC | 1.45500641 |
| 38 | MARK3 | 1.41734065 |
| 39 | JAK3 | 1.39352248 |
| 40 | HCK | 1.38571685 |
| 41 | SRPK1 | 1.38358787 |
| 42 | BMPR2 | 1.35462457 |
| 43 | MAP3K4 | 1.35327054 |
| 44 | LYN | 1.34825035 |
| 45 | PNCK | 1.34623121 |
| 46 | CSK | 1.34153692 |
| 47 | PLK2 | 1.33989178 |
| 48 | MYLK | 1.28121957 |
| 49 | TBK1 | 1.26673429 |
| 50 | ARAF | 1.25207095 |
| 51 | PIK3CG | 1.24919115 |
| 52 | FGR | 1.23614079 |
| 53 | IKBKE | 1.23577809 |
| 54 | ITK | 1.21868246 |
| 55 | CDK19 | 1.20989013 |
| 56 | MAP3K1 | 1.20188236 |
| 57 | MINK1 | 1.19065943 |
| 58 | GRK5 | 1.17609038 |
| 59 | NTRK3 | 1.15583790 |
| 60 | TSSK6 | 1.15491793 |
| 61 | OXSR1 | 1.15413567 |
| 62 | MUSK | 1.15393694 |
| 63 | TAOK1 | 1.14644270 |
| 64 | STK38L | 1.13497732 |
| 65 | BMX | 1.10894209 |
| 66 | AKT3 | 1.09500832 |
| 67 | KIT | 1.07997071 |
| 68 | TRPM7 | 1.07431588 |
| 69 | ADRBK2 | 1.07093679 |
| 70 | EIF2AK1 | 1.05210269 |
| 71 | EIF2AK3 | 1.04690249 |
| 72 | MAP3K7 | 1.04126619 |
| 73 | CSF1R | 1.03024840 |
| 74 | BMPR1B | 1.02974355 |
| 75 | SIK3 | 1.01490388 |
| 76 | EPHA4 | 0.97054116 |
| 77 | JAK2 | 0.96549936 |
| 78 | NEK1 | 0.93650315 |
| 79 | EPHB1 | 0.93389577 |
| 80 | CAMK2D | 0.92136262 |
| 81 | CCNB1 | 0.90945118 |
| 82 | LCK | 0.90888975 |
| 83 | MAP2K6 | 0.89425466 |
| 84 | MATK | 0.89271181 |
| 85 | PRPF4B | 0.89154575 |
| 86 | LMTK2 | 0.88413140 |
| 87 | OBSCN | 0.87900850 |
| 88 | CAMK2B | 0.85857507 |
| 89 | MAPK13 | 0.85369207 |
| 90 | VRK1 | 0.85131410 |
| 91 | JAK1 | 0.84987956 |
| 92 | CAMK2A | 0.81120717 |
| 93 | MST4 | 0.78929610 |
| 94 | NEK6 | 0.78837964 |
| 95 | CDC42BPA | 0.78170259 |
| 96 | TAOK2 | 0.77364551 |
| 97 | MAPK12 | 0.77073646 |
| 98 | CAMK2G | 0.77009280 |
| 99 | BCR | 0.76648378 |
| 100 | MAP2K4 | 0.76144318 |
| 101 | PRKCG | 0.75492202 |
| 102 | PDK1 | 0.75025983 |
| 103 | BRAF | 0.73866017 |
| 104 | TGFBR2 | 0.72085901 |
| 105 | PRKCE | 0.71821404 |
| 106 | MAP2K1 | 0.71383682 |
| 107 | EIF2AK2 | 0.69579043 |
| 108 | PRKCI | 0.68898539 |
| 109 | STK39 | 0.68567111 |
| 110 | DAPK1 | 0.67011012 |
| 111 | MAP4K2 | 0.66470039 |
| 112 | PDPK1 | 0.65514543 |
| 113 | PHKG1 | 0.64678359 |
| 114 | PHKG2 | 0.64678359 |
| 115 | PRKAA2 | 0.64569027 |
| 116 | HIPK2 | 0.62506720 |
| 117 | PRKCQ | 0.62449681 |
| 118 | CDK3 | 0.61880921 |
| 119 | WEE1 | 0.61804534 |
| 120 | BCKDK | 0.60022384 |
| 121 | PRKD2 | 0.59636294 |
| 122 | KSR2 | 0.58408525 |
| 123 | PLK3 | 0.58316955 |
| 124 | STK38 | 0.57994378 |
| 125 | PKN1 | 0.56801192 |
| 126 | MAP2K2 | 0.56634905 |
| 127 | EPHA2 | 0.56105168 |
| 128 | MAPKAPK5 | 0.55890407 |
| 129 | INSRR | 0.55827799 |
| 130 | CAMKK1 | 0.54532534 |
| 131 | DYRK2 | 0.54049174 |
| 132 | WNK4 | 0.53946117 |
| 133 | ABL2 | 0.53823285 |
| 134 | AURKA | 0.52586591 |
| 135 | TTK | 0.51940416 |
| 136 | TXK | 0.50846261 |
| 137 | RPS6KA6 | 0.50823557 |
| 138 | ROCK2 | 0.50700112 |
| 139 | EPHA3 | 0.50575436 |
| 140 | MAP3K2 | 0.49697312 |
| 141 | PBK | 0.48410045 |
| 142 | DAPK2 | 0.48264105 |
| 143 | NTRK2 | 0.48117028 |
| 144 | STK24 | 0.48074534 |
| 145 | CAMKK2 | 0.46940878 |
| 146 | PIM1 | 0.46529593 |
| 147 | PIM2 | 0.44274595 |
| 148 | CSNK1G3 | 0.43800704 |
| 149 | TESK2 | 0.43610534 |
| 150 | ADRBK1 | 0.43406375 |
| 151 | MAPK11 | 0.41832850 |
| 152 | MAP3K5 | 0.41348424 |
| 153 | CHUK | 0.38702962 |
| 154 | TNK2 | 0.38627679 |
| 155 | SGK223 | 0.38133524 |
| 156 | SGK494 | 0.38133524 |
| 157 | RPS6KA5 | 0.37908962 |
| 158 | PRKACA | 0.37471804 |
| 159 | PRKG2 | 0.35204822 |
| 160 | MAPK7 | 0.34920204 |
| 161 | RAF1 | 0.34809952 |
| 162 | YES1 | 0.34422405 |
| 163 | ABL1 | 0.33215606 |
| 164 | SGK2 | 0.32435700 |
| 165 | CAMK1 | 0.32403430 |
| 166 | MAPKAPK3 | 0.31424123 |
| 167 | STK4 | 0.31122070 |
| 168 | FYN | 0.30387230 |
| 169 | PLK1 | 0.30272176 |
| 170 | MAP3K14 | 0.30063700 |
| 171 | GRK1 | 0.28426096 |
| 172 | TLK1 | 0.27628083 |
| 173 | CDK5 | 0.27377705 |
| 174 | WNK3 | 0.26998547 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 5.55683637 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 4.65831744 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.58779432 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 3.42709449 |
| 5 | Huntingtons disease_Homo sapiens_hsa05016 | 3.35995897 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.81740673 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.71866683 |
| 8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.66637954 |
| 9 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.61237300 |
| 10 | Nicotine addiction_Homo sapiens_hsa05033 | 2.49280615 |
| 11 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.43636624 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.30341387 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.29973704 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.28919203 |
| 15 | Leishmaniasis_Homo sapiens_hsa05140 | 2.14546781 |
| 16 | Malaria_Homo sapiens_hsa05144 | 2.13736494 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.11531429 |
| 18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.06020856 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 2.03886676 |
| 20 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03544442 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.98398951 |
| 22 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.98226287 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93245373 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.91940727 |
| 25 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.88836339 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.83481083 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.81855369 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.74741416 |
| 29 | Platelet activation_Homo sapiens_hsa04611 | 1.71298569 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.68419239 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68371880 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.67394863 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.66284878 |
| 34 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.60470374 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.59334492 |
| 36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55061192 |
| 37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52844171 |
| 38 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50821784 |
| 39 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.48862289 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.47832214 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.45095643 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.45075532 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39262275 |
| 44 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.36093202 |
| 45 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.31898968 |
| 46 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.31024537 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.29766552 |
| 48 | Taste transduction_Homo sapiens_hsa04742 | 1.27841059 |
| 49 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.26549666 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.23725282 |
| 51 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.23118911 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.22825508 |
| 53 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20819944 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 1.19264208 |
| 55 | Purine metabolism_Homo sapiens_hsa00230 | 1.18091773 |
| 56 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.17827716 |
| 57 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.13062488 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.11512940 |
| 59 | Protein export_Homo sapiens_hsa03060 | 1.11063552 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08992676 |
| 61 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.06020048 |
| 62 | Measles_Homo sapiens_hsa05162 | 1.04922366 |
| 63 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.04423670 |
| 64 | DNA replication_Homo sapiens_hsa03030 | 1.04261493 |
| 65 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.03380285 |
| 66 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.02378571 |
| 67 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.02245819 |
| 68 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.02089223 |
| 69 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.01420670 |
| 70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.00493449 |
| 71 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.99468431 |
| 72 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.96314005 |
| 73 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95819382 |
| 74 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94878835 |
| 75 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.94216273 |
| 76 | Metabolic pathways_Homo sapiens_hsa01100 | 0.94111680 |
| 77 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93376454 |
| 78 | Homologous recombination_Homo sapiens_hsa03440 | 0.93279665 |
| 79 | Mismatch repair_Homo sapiens_hsa03430 | 0.91798906 |
| 80 | GABAergic synapse_Homo sapiens_hsa04727 | 0.91616176 |
| 81 | Basal transcription factors_Homo sapiens_hsa03022 | 0.91476930 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.90483247 |
| 83 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.90356277 |
| 84 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.89425902 |
| 85 | Influenza A_Homo sapiens_hsa05164 | 0.89074283 |
| 86 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87657021 |
| 87 | Morphine addiction_Homo sapiens_hsa05032 | 0.87465229 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.86250415 |
| 89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86138323 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.84789124 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.84411721 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.84243657 |
| 93 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.83508859 |
| 94 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.83422426 |
| 95 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.83111663 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.79503744 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.79174633 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78949173 |
| 99 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78624813 |
| 100 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77446977 |
| 101 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76471168 |
| 102 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.76212349 |
| 103 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75514358 |
| 104 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.73486618 |
| 105 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.73279770 |
| 106 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72324005 |
| 107 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.70655035 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.70547841 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70508692 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.69941109 |
| 111 | Viral myocarditis_Homo sapiens_hsa05416 | 0.69852669 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.69048028 |
| 113 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.67889112 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65261899 |
| 115 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.63136566 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61196450 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.60685946 |
| 118 | Pertussis_Homo sapiens_hsa05133 | 0.60574838 |
| 119 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.59724930 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54610794 |
| 121 | Carbon metabolism_Homo sapiens_hsa01200 | 0.54417931 |
| 122 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.54149503 |
| 123 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53647896 |
| 124 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52700384 |
| 125 | Hepatitis C_Homo sapiens_hsa05160 | 0.51847687 |
| 126 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51846830 |
| 127 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51753678 |
| 128 | Shigellosis_Homo sapiens_hsa05131 | 0.51741576 |
| 129 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50593840 |
| 130 | Peroxisome_Homo sapiens_hsa04146 | 0.49970643 |
| 131 | RNA degradation_Homo sapiens_hsa03018 | 0.49829234 |
| 132 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.47895796 |
| 133 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46408471 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46155921 |
| 135 | Phagosome_Homo sapiens_hsa04145 | 0.45951313 |
| 136 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44765946 |
| 137 | Hepatitis B_Homo sapiens_hsa05161 | 0.43185714 |
| 138 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42056276 |
| 139 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.40547887 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.40412493 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.40228441 |
| 142 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38879221 |
| 143 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.38743273 |
| 144 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38555381 |
| 145 | Spliceosome_Homo sapiens_hsa03040 | 0.38082469 |
| 146 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.37448019 |
| 147 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.37380646 |
| 148 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37142005 |
| 149 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36122140 |
| 150 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.35437396 |
| 151 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.34811710 |
| 152 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34024836 |
| 153 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.32489970 |
| 154 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.31930556 |
| 155 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.31865908 |
| 156 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.31297028 |
| 157 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.31071556 |
| 158 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.30624187 |
| 159 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30333886 |
| 160 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.30179290 |
| 161 | Insulin secretion_Homo sapiens_hsa04911 | 0.30119981 |
| 162 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.29283432 |
| 163 | Salivary secretion_Homo sapiens_hsa04970 | 0.29208397 |
| 164 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.28499811 |
| 165 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.27607373 |
| 166 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.26772395 |
| 167 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.25769352 |
| 168 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24247399 |
| 169 | Cocaine addiction_Homo sapiens_hsa05030 | 0.22645154 |
| 170 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.20673407 |
| 171 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.19945146 |
| 172 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.19343753 |

